Meet Strata

Advanced algorithmic biomarkers for antibody drug conjugates and immunotherapy

Our mission is to accelerate the impact of precision medicine for patients with cancer.

About us 1

Our Leaders

Dan Rhodes, PhD
Dan Rhodes, PhD

Co-Founder & CEO

Scott Tomlins, MD, PhD
Scott Tomlins, MD, PhD

Co-founder & Chief Medical Officer

Catherine Sazdanoff
Catherine Sazdanoff

Chief Business Development Officer & Chief Compliance and Legal Officer

Bryan Johnson
Bryan Johnson

Chief Data Scientist

Matt Martin, MBA
Matt Martin, MBA

Chief Financial Officer

ScottN
Scott Nisbet

VP, Business Development

Our Values

About us 4
1/7

Start with the patient

Focus on the patient first and all else will follow.

2/7

Think big

We never settle — in everything we do, we push against boundaries and think boldly to achieve life-changing results for patients.

3/7

Embrace the journey.

Building the leading precision oncology company requires unrivaled vision, innovation and execution. We take pride in our work and celebrate wins along the way.

4/7

Apply a scientific mindset

We move quickly and deliberately, using a logical and data-driven approach to guide our decisions and achieve breakthroughs. We hold ourselves mutually accountable to achieving transformative results.

5/7

Best idea wins

We challenge assumptions to foster innovation and create the best possible solution. In doing so, we actively listen with humility and respect.

6/7

Strive for the highest bar

Given our responsibility to each other and patients with cancer, we expect excellence and integrity in all that we do. We do the right thing because there is no alternative.

7/7

Have fun & embrace the team

We collaborate and celebrate. We believe in building relationships with our coworkers because greatness comes from unlocking each other’s potential.

The company we keep

Board of Directors

Keith Flaherty, MD

Co-founder Strata Oncology, Professor, Harvard Medical School, Director of Clinical Research, Massachusetts General Hospital Cancer Center

Jan Garfinkle

Founder and Managing Partner, Arboretum Ventures

Michael Liang, PhD

Partner, Baird Capital

Chris O’Donnell, PhD

Partner and Executive Director, Pfizer Ventures

Dan Rhodes, PhD

President & CEO, Co-founder, Strata Oncology

Prem Tumkosit

Managing Director, Merck Global Health Innovation Fund, LLC Merck Global Health Innovation Group

Jeff Williams

Executive Chairman of the Board

Our Investors

Investor Logos=Wellington Management Logo Investor Logos=Cormorant Asset management Logo Investor Logos=Arboretum Logo Investor Logos=Merck Logo Investor Logos=HighSide Capital Managment Logo Investor Logos=Pfizer Logo Investor Logos=Monashee Investment Management Logo Investor Logos=Renaissance Venture Capital Logo Investor Logos=Deerfield Logo Investor Logos=Baird Capital Logo
Work for Strata Oncology

Join our team

Work for Strata Oncology

We are always looking for people that share our vision. Join us to create a new precision oncology, standard of care.

LinkedIn careers LinkedIn careers
AICPA_SOC_21972-312_NonCPA_sm2

Strata Oncology has achieved SOC 2 compliance. This certification attests to the company’s commitment to protecting customer data and adhering to best practices in security and privacy infrastructure.

SOC 2 is a set of standards developed by the American Institute of Certified Public Accountants (AICPA) to provide customer assurance of a service provider’s system and operations. Compliance with these standards demonstrates that Strata Oncology has achieved the highest level of security, privacy, availability, and confidentiality for its services